1 Are we ready for an audit/inspection as a CRO? Clinical Research Association Istanbul – 01DEC2007 Tony Owen, Vice-President QA Europe.

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Tips to a Successful Monitoring Visit
Steve Fuller InforMedix Marketing Research, Inc. Medical-Surgical Market Research Group April 3, 2008.
Enhancing the CRO-Sponsor Collaboration to Ensure High Quality of Clinical Data May 17,2011 | Beijing, China Charles Yan, PhD Shanghai Clinical Research.
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
ORGANIZATION. 2 Purchasing & Inventory Assessment Occurrence Management Information Management Process Improvement Customer Service Facilities & Safety.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
IAEA International Atomic Energy Agency. IAEA Outline Learning objectives Introduction Functions of Regulatory Body (RB) on EPR Appraisal guidance: Part.
Practical Effective Steps to Improve Trial QUALITY from Audit/Inspections findings Cancer Clinical Trials Unit Scotland A NCRI Accredited Cancer Trials.
Cheryl McCarthy Manager, Quality Assurance MBC Session October 3, 2008 GCP Compliance in our Vendors.
BRC Storage & Distribution Safety and Quality Management System Training Guide
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
The ISO 9002 Quality Assurance Management System
Virtual Environmental, Health & Safety Manager Compliance Management System T. Cozzie Consulting, Inc. telephone
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
What SMS means for an Operator’s relationship with the CAA
ISO Energy Management System Certification
AUDITS AND INSPECTIONS
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
© 2011 Michigan State University and United Nations Industrial Development Organization, original at CC-BY-SA Complaint Handling.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
ATMC 10 - Kuwait 29th Nov - 1st Dec AABB Accreditation Salwa Hindawi President of Saudi Society of Transfusion Medicine Medical Director of Blood.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Authorization and Inspection of Cyclotron Facilities Inspections.
Please read before using this briefing This presentation forms the basis of a workshop for operational managers and other relevant staff to review quality.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
Audits and Inspections in Clinical Research Jobin Kunjumon Vilapurathu.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Fourth Annual Medical Research Summit Concurrent Session 4.05 – Managing CROs and SMOs from a Compliance Perspective Michael SwiatochaAprill 23, 2004.
Monitoring, Audits, and Inspection Oh my! Rachel Sheppard Regulatory Director, OCRSS.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Module N° 8 – SSP implementation plan. SSP – A structured approach Module 2 Basic safety management concepts Module 2 Basic safety management concepts.
The Patient’s Health Record / Chart. Standards HS-AHI-5. Students will outline the evolution of a client’s medical record and analyze the purpose, utilization,
Georgia Institute of Technology CS 4320 Fall 2003.
Connecting the Dots A Practical Approach to Integrating Compliance, Risk and Quality Jody Ann Noon RN, JD Partner Health Care Regulatory Practice.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
SHOPS is funded by the U.S. Agency for International Development. Abt Associates leads the project in collaboration with Banyan Global Jhpiego Marie Stopes.
Agenda for Session Compliance in Clinical Research
How to Start An Industry Sponsored Clinical Trial
organization – status 2015 – scheme – integrity program – strategy
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Office of Human Research Protection Georgia Health Sciences University.
OTC Pres Project Del P5 12/08 Page 1 Project Delivery Performance Improvement Report to the Oregon Transportation Commission Jeff Gower, State Construction.
Welcome. Registration complete? CQC Inspection visit Routine Responsive Themed.
Compliance at the Crossroads: How can the Compliance Profession Move to the Second Generation? A Practical Approach to Integrating Compliance, Risk and.
Trial Master Files – the De-Centralised Communication Challenge Karen Roy.
LESSONS LEARNED FROM RECENT PIPELINE INCIDENTS FLORIDA NATURAL GAS ASSOCIATION (FNGA) OPERATING & MARKETING CONFERENCE ROD WALKER PRINCIPAL CONSULTANT.
Documentation Requirements for Hospital Accreditation -By Global Manager Group.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Care Quality Commission (CQC) Registration. Background The Care Quality Commission (CQC) is the health and social care regulator for England. From 1 April.
Quality Assurance and Quality Control in Longitudinal Studies Coralyn W. Whitney, Bonnie K. Lind, and Patricia W. Wahl Epidemiologic Reviews, 1998, Vol.
Surviving CTIMPs and MHRA inspections Kim Gooding Diabetes and Vascular Medicine UEMS and Exeter CRF Exeter Clinical Research Facility.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Responsibilities of Test Facility Management, Study Director, Principal Investigator and Study Personnel G. Jacobs Belgian GLP Monitorate Zagreb, 17 December.
NANCY CHOBIN, RN, AAS, ACSP, CSPM, CFER CHOBIN & ASSOCIATES CONSULTING HOT TOPICS IN STERILIZATION AND DISINFECTION.
Presented By Copyright 2011 Concord Associates Pte Ltd ConSASS Audit and Auditor’s Key Observations.
Business Considerations in eTMF Implementation Karen Roy Phlexglobal Ltd.
Responsibilities of Sponsor, Investigator and Monitor
Quality System Deployment in a Clinical Trials Vendor Environment Jeffrey Brandt Quality Assurance Manager Rocky Mountain Poison and Drug Center First.
“Your sustainable compliance and remediation partners”
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
Responsibilities of Sponsor, Investigator and Monitor
ISO/IEC
Pharmaceutical Quality in the 21st Century
Medicines Management Tips & Preparing for your CQC Inspection with Gerry Devine Practice Management Advisor.
Technical Meeting on Regulatory Oversight of Human and Organizational Factors Vienna, Austria | December 2015 Breakout sessions 2.
Presentation transcript:

1 Are we ready for an audit/inspection as a CRO? Clinical Research Association Istanbul – 01DEC2007 Tony Owen, Vice-President QA Europe

2 Content  What are my credentials?  Quintiles Experience  When do you start preparing?  Quality Management System  Who’s your best friend internally?  Internal QA programme  What to do when the inspection is announced?  Preparation for audit/inspections

3 Quintiles - Inspection Experience in Europe (2007 to date)  1999 – 5  2000 – 16  2001 – 21  2002 – 26  2003 – 41  2004 – 23  2005 – 13  2006 – 42  2007 – 60  2006 first inspection in Turkey  FDA Investigator Site Inspection  No FD483 Inspectors are like busses! You never know when the next one will arrive!

4 Quintiles inspection experience - With various inspection agencies (end 2Q07)

5 Quality Management System  Regulations  SOPs  Training and development  Validated computer systems  Management oversight  Quality Control  Quality Assurance  Records of all the above When do you start preparing for an inspection? “There is no time like the present.”

6 Internal QA Programme  QA - Service function  QA Services  Audits  Metrics  Quality Issue management  Consultancy – quality related queries  Host customer audits/ regulatory inspections  Training (some)  Quality Planning  QA Leads QA is your best friend!!!

7 Internal Audit Programme  Audit All Pivotal studies  As a minimum:  Quality Planning Team meetings  In Trial  2 In Depth Site Audits per project  Additional projects can be included in the internal audit programme as deemed necessary by QA.  Non-pivotal studies - occasional telephone audits  Process and computer systems audits Internal audit programme to complement the sponsor audit programme, not replace it

8 Audits - Do different types to drive improvement e.g.:  Scorecard audits  Select Key Performance indicators  Audit across offices  Score the results and publish  Develop action plans  Repeat to drive improvement  Telephone audits  Interviews with groups of CRAs  Set questions  Publish – this is what you need to know about your st

9 Metrics - Make the most of information you have  Collate audit data  Enter into a database  Produce regular operational metrics  Analyse findings – introduce preventive actions  Drive improvement

10 Quality Planning - Prepare for inspection before study starts!  QA, PM, CTL, Medical Advisor, Regulatory Affairs, others  “What could kill this study in an inspection?” e.g.:  Cannot demonstrate correct diagnosis  Efficacy measures inconsistent  Supplies not stored correctly  Identify the risks e.g.:  For each key diagnostic, efficacy and safety test  What equipment/experience is required?  How will this be communicated and documented?  What consistency checks are required to be performed?  What evidence will be required?  Mitigate the risk  Plan, instruct, monitor correct

11 What to do when an inspection is announced!  Prepare sometimes - It’s not always sensible/possible!  Low risk  Brief investigator site inspections  e.g. Germany, Greece, Hungary, Bulgaria  Intermediate risk  More intensive site inspections, may include visit to sponsor/CRO facilities  e.g. France, Italy, Finland, Ireland, Austria  High risk  Intensive, sites and sponsor/CRO facilities  Evaluation of sponsor/CRO processes  Can extend into other parts of business  e.g. EMEA, FDA, UK-MHRA The last chance saloon!

12 A Possible Strategy for Inspection Management

13 Quintiles Preparation - Intermediate and High Risk Inspections  QA pre-inspection (as soon as possible)  Focus on processes, computer systems, and projects  Interview staff and review documents  Agree action plan  Follow up on actions  Place third parties on stand by  Train staff in handling inspections  Encourage staff in their knowledge and abilities

14 Thank you!